98%
921
2 minutes
20
Background: The telovelar approach provides access to the caudal two-thirds of the fourth ventricle without requiring vermian splitting. Indeed, the traditional microsurgical approach is often limited by a restricted cranial angle of attack and visualization, making it challenging to evaluate the patency of the aqueduct. To address this limitation, resection of the posterior arch of C1 is frequently performed. This study aims to describe and evaluate the feasibility of a full-endoscopic, retractorless, trans-Magendie approach to the inferior third of the fourth ventricle, avoiding removal of the posterior arch of C1 through a minimally invasive burr-hole suboccipital craniotomy.
Methods: Four formalin-fixed, injected cadaveric heads were investigated. A step-by-step anatomic description of the proposed approach is provided.
Results: Adequate cranial and lateral visualization of the aqueduct and fourth ventricle floor was achieved without removing the posterior arch of C1.
Conclusions: The full-endoscopic trans-Magendie approach enables adequate visualization of the inferior two-thirds of the fourth ventricle and the caudalmost portion of the aqueduct while avoiding the need for a C1 laminectomy and significantly reducing the craniotomy size.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.wneu.2025.124062 | DOI Listing |
Clin Exp Metastasis
September 2025
Department of Neurosurgery, Warren Alpert Medical School of Brown University, 593 Eddy Street - APC 6, Providence, RI, 02903, USA.
Significant variability exists in the use of corticosteroids for treating adverse radiation effects (ARE) after stereotactic radiosurgery (SRS) of brain metastasis (BM). Here, we determine the diagnostic utility of a quadrant-based, visual assessment of magnetic resonance (MR) FLAIR as an imaging biomarker for steroid-dependent ARE. FLAIR was assessed at four axial levels along the rostral-caudal axis of the cerebrum, defined by standard landmarks of superior temporal line, third ventricle, temporal horn, and fourth ventricle.
View Article and Find Full Text PDFNeurochem Res
September 2025
School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA, 71201, USA.
Alpha-2 (α2-) tanycytes line the ventral wall of the third ventricle where they ostensibly engage in metabolic screening. The oxidizable glycolytic end-product L-lactate is a gauge of hindbrain energy stability that is imparted to forebrain glucose-regulatory loci by norepinephrine signaling. Current research used a validated whole-animal model for insulin-induced hypoglycemia (IIH) to address the premise that hindbrain lactate status imposes sex-specific control of eu- and/or hypoglycemic patterns of α2-tanycyte chemosensor gene transcription in vivo.
View Article and Find Full Text PDFToxoplasmosis is a common opportunistic infection in immunocompromised patients. Cerebral toxoplasmosis can be the initial manifestation of acquired immunodeficiency syndrome (AIDS). We report a case diagnosed at autopsy as the primary presentation of an undiagnosed human immunodeficiency virus (HIV)-positive patient.
View Article and Find Full Text PDFCureus
July 2025
Department of Neurosurgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, JPN.
Subependymoma is a benign, slow-growing tumor that arises from the ventricular wall. Although often asymptomatic, it can obstruct cerebrospinal fluid flow, leading to hydrocephalus. Most subependymomas are unilateral, typically located in the fourth ventricle, followed by the lateral ventricles.
View Article and Find Full Text PDFNeurotherapeutics
August 2025
Department of Neurology, Punan Branch of Renji Hospital, Shanghai Jiao Tong University School of Medicine (Punan Hospital in Pudong New District, Shanghai), Shanghai, 200125, China. Electronic address:
This study investigates distinct neuroinflammatory patterns in neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD) using multi-tracer PET and MR imaging. Eight NMOSD (5F/3M; median age 36.5) and six MOGAD patients (2F/4M; median age 34.
View Article and Find Full Text PDF